Sign In
Buy VXRT
$0.519
-0.0111 (-2.09%)
At Close: Jun 23, 2026
Vaxart, Inc. Set to Join Russell 3000® Index
08:00am, Wednesday, 24'th Jun 2020
SOUTH SAN FRANCISCO, Calif., June 24, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing oral recombinant vaccines that are
Vaxart Gets New CEO, Focuses on Coronavirus Vaccine Program
10:45am, Tuesday, 16'th Jun 2020
Vaxart (VXRT) management names Andrei Floroiu as its next chief executive officer with immediate effect. Stock appreciates on this news.
Vaxart, Inc. Appoints New CEO to Accelerate Advancement of COVID-19 and Other Programs
07:30am, Monday, 15'th Jun 2020
Andrei Floroiu Appointed Chief Executive Officer Wouter Latour, MD, to Continue as Chairman of the Board
Vaxart to Present at the Jefferies Virtual Healthcare Conference
08:00am, Wednesday, 03'rd Jun 2020
SOUTH SAN FRANCISCO, Calif., June 03, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. (“Vaxart” or the “Company”) (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral recombinant va
Vaxart Announces Selection of its Oral COVID-19 Vaccine Lead Candidate
08:00am, Wednesday, 20'th May 2020
KindredBio Selected as Second Contract Manufacturing Organization
Vaxart Announces First Quarter 2020 Financial Results and Provides Corporate Update
04:01pm, Tuesday, 12'th May 2020
Lead Vaccine Candidates for COVID-19 are Highly Immunogenic in Preclinical Testing
Vaxart (VXRT) to Report Q1 Earnings: What's in the Cards?
12:47pm, Wednesday, 29'th Apr 2020
During Vaxart's (VXRT) upcoming Q1 earnings call, investor focus will be on the company's progress with its oral vaccine candidates against SARS CoV-2.
Why Vaxart Stock Slumped Today
05:01pm, Tuesday, 28'th Apr 2020
The company released preliminary first-quarter results.
Why Vaxart Is Soaring Today
12:23pm, Monday, 27'th Apr 2020
The biotech company is benefiting from an overall rise in the stock market.
Vaxart Up on Pre-Clinical Data on Coronavirus Vaccine Candidates
11:19am, Wednesday, 22'nd Apr 2020
Vaxart's (VXRT) several COVID-19 vaccine candidates generate immune responses in pre-clinical studies. Stock rises.
Vaxart Announces Positive Pre-Clinical Data for its Oral COVID-19 Vaccine Program
08:00am, Tuesday, 21'st Apr 2020
Lead Vaccine Candidates Generate Anti-SARS CoV-2 Antibodies in All Tested Animals after First Dose Lead Vaccine Candidates Generate Anti-SARS CoV-2 Antibodies in All Tested Animals after First Dose
Buy 5 Top Medical Stocks on Coronavirus Drug Trial Results
07:20am, Friday, 17'th Apr 2020
The whole world has pinned hopes on pharmaceutical and biotech companies to create drugs and vaccine to help combat COVID-19.
Expand Pharmacists’ Authority To Promote COVID-19 Vaccine Access
05:33pm, Tuesday, 31'st Mar 2020
Just like the flu vaccine, pharmacists should be empowered to administer the COVID-19 vaccine to patients in every state.
Top Sectors of Q1 & Their Winning Stocks
07:45am, Tuesday, 31'st Mar 2020
Inside the top-performing sectors of Q1 and their winning stocks.
5 Stocks to Buy That Are Holding Strong While Everything Else Crumbles
02:17pm, Thursday, 26'th Mar 2020
Unlike the broader market, these stocks to buy have managed to hold up strong amid the ongoing public health crisis.
